Lynn C Goldstein

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

L. Goldstein, A. Gown, T. Barry, 2008, Modern Pathology.

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

Jong-Hyeon Jeong, Hanna Bandos, Debora Fumagalli, 2013, Journal of the National Cancer Institute.

Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.

Karen A Gelmon, David Huntsman, C Blake Gilks, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.